These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

573 related articles for article (PubMed ID: 23402694)

  • 41. The specificity of referential thinking: a comparison of schizotypy and social anxiety.
    Meyer EC; Lenzenweger MF
    Psychiatry Res; 2009 Jan; 165(1-2):78-87. PubMed ID: 19059651
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A temporal examination of co-activated emotion valence networks in schizophrenia and schizotypy.
    Cohen AS; Callaway DA; Mitchell KR; Larsen JT; Strauss GP
    Schizophr Res; 2016 Feb; 170(2-3):322-9. PubMed ID: 26711714
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The latent structure and coincidence of hypohedonia and schizotypy and their validity as indices of psychometric risk for schizophrenia.
    Linscott RJ
    J Pers Disord; 2007 Jun; 21(3):225-42. PubMed ID: 17536937
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A meta-analysis of context integration deficits across the schizotypy spectrum using AX-CPT and DPX tasks.
    Chun CA; Ciceron L; Kwapil TR
    J Abnorm Psychol; 2018 Nov; 127(8):789-806. PubMed ID: 30431288
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Episodic memory retrieval is impaired in negative schizotypy under fast response deadline.
    Sahakyan L; Kwapil TR
    Schizophr Res; 2018 Nov; 201():167-171. PubMed ID: 29880452
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Schizotypy: phenotypic marker as risk factor.
    Catts SV; Fox AM; Ward PB; McConaghy N
    Aust N Z J Psychiatry; 2000 Nov; 34 Suppl():S101-7. PubMed ID: 11129293
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Do measures of schizotypal personality provide non-clinical analogues of schizophrenic symptomatology?
    Cochrane M; Petch I; Pickering AD
    Psychiatry Res; 2010 Apr; 176(2-3):150-4. PubMed ID: 20219252
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The relationship between schizotypal ideation and subjective cognition reflects more than just cognitive disorganisation: introducing the Brief Cognitive Schizotypy Index.
    Corcoran R; Devan K; Durrant S; Liddle P
    Cogn Neuropsychiatry; 2013; 18(6):491-514. PubMed ID: 23193969
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Schizotypy and individual differences in the frequency of normal associations in verbal utterances.
    Lenzenweger MF; Miller AB; Maher BA; Manschreck TC
    Schizophr Res; 2007 Sep; 95(1-3):96-102. PubMed ID: 17628440
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cannabis use and schizotypy: the role of social anxiety and other negative affective states.
    Najolia GM; Buckner JD; Cohen AS
    Psychiatry Res; 2012 Dec; 200(2-3):660-8. PubMed ID: 22920791
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Developing psychosis and its risk states through the lens of schizotypy.
    Debbané M; Eliez S; Badoud D; Conus P; Flückiger R; Schultze-Lutter F
    Schizophr Bull; 2015 Mar; 41 Suppl 2(Suppl 2):S396-407. PubMed ID: 25548386
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The association of multidimensional schizotypy with symptoms and impairment across racial groups.
    Rbeiz KS; Clark HE; Kemp KC; Bathery AJ; Monette MA; Barrantes-Vidal N; Kwapil TR
    Personal Ment Health; 2022 Feb; 16(1):79-89. PubMed ID: 34528403
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Behavioral signs of schizoidia and schizotypy in social anhedonics.
    Collins LM; Blanchard JJ; Biondo KM
    Schizophr Res; 2005 Oct; 78(2-3):309-22. PubMed ID: 15950438
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Objective and subjective olfaction across the schizophrenia spectrum.
    Auster TL; Cohen AS; Callaway DA; Brown LA
    Psychiatry; 2014; 77(1):57-66. PubMed ID: 24575913
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Affecting coping: does neurocognition predict approach and avoidant coping strategies within schizophrenia spectrum disorders?
    MacAulay R; Cohen AS
    Psychiatry Res; 2013 Sep; 209(2):136-41. PubMed ID: 23680466
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The Schizotypic Syndrome Questionnaire (SSQ): Psychometrics, validation and norms.
    van Kampen D
    Schizophr Res; 2006 Jun; 84(2-3):305-22. PubMed ID: 16580180
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cannabis and psychometrically-defined schizotypy: use, problems and treatment considerations.
    Cohen AS; Buckner JD; Najolia GM; Stewart DW
    J Psychiatr Res; 2011 Apr; 45(4):548-54. PubMed ID: 20851410
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Negative symptoms in psychometrically defined schizotypy: The role of depressive symptoms.
    Campellone TR; Elis O; Mote J; Sanchez AH; Kring AM
    Psychiatry Res; 2016 Jun; 240():181-186. PubMed ID: 27111211
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Emotion processing deficits in the different dimensions of psychometric schizotypy.
    Giakoumaki SG
    Scand J Psychol; 2016 Jun; 57(3):256-70. PubMed ID: 27119257
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Psychometric properties and concurrent validity of the schizotypal ambivalence scale.
    Kwapil TR; Mann MC; Raulin ML
    J Nerv Ment Dis; 2002 May; 190(5):290-5. PubMed ID: 12011608
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.